[Inhaled corticosteroids and wheezing post-bronchiolitis]

Area of Science:

• Pediatric respiratory medicine
• Clinical pharmacology
• Evidence-based medicine

Background:

• Bronchiolitis is a common viral respiratory infection in infants.
• Wheezing is a frequent symptom following bronchiolitis, impacting subsequent respiratory health.
• The efficacy of inhaled corticosteroids in preventing post-bronchiolitis wheezing requires further investigation.

Purpose of the Study:

• To evaluate the effectiveness of inhaled beclomethasone in reducing wheezing incidence and severity post-mild bronchiolitis.
• To assess the long-term impact of a 3-month inhaled corticosteroid course on infant wheezing.

Main Methods:

• A multicenter, randomized, single-blind, controlled intervention study.
• 94 infants under 12 months with mild bronchiolitis were enrolled.
• One group received 3 months of inhaled beclomethasone; the control group received no treatment.

Main Results:

• 89 infants completed the study; 67% experienced wheezing during the 15-month study period.
• No statistically significant differences in the number or severity of wheezing episodes were observed between the beclomethasone and control groups.
• The treatment did not alter wheezing occurrence during the intervention or the subsequent 12-month follow-up.

Conclusions:

• A 3-month course of inhaled beclomethasone is not effective in significantly altering the occurrence or severity of wheezing in infants following mild bronchiolitis.
• Current evidence does not support the use of inhaled corticosteroids for preventing recurrent wheezing episodes after mild bronchiolitis.